Investigate the Complex Field of ID
Dive into the interesting and complex world of infectious diseases with the Dr. John G. Bartlett Education Series. Dedicated to the thought leadership and groundbreaking work of John G. Bartlett, MD, FIDSA, this series features lectures by esteemed ID professionals and patient advocates in the areas of C. diff, HIV, COVID-19, antimicrobial drug resistance and more.
The Dr. John G. Bartlett Education Series also includes previously-recorded talks by Dr. Bartlett on various infectious diseases, including the story behind the elimination of the deadly scourge of smallpox, now only a historic footnote due to a successful vaccination program.
Previous webinars
Advancing HIV Prevention: Strategies, Treatments and Community Impact
Air Date: Tuesday, December 3, 2024
Sponsored by: GILEAD
In honor of World AIDS Day, the IDSA Foundation hosted a webinar which focused on advancing HIV prevention and providing updates to equip healthcare professionals with the knowledge and skills needed to make a meaningful impact in their practice. Attendees explored the latest advancements in HIV treatment and prevention, examined current trends, and learned about new treatments in development. The webinar illustrated effective strategies, demonstrated their application, and guided participants on translating this knowledge into practice.
Recurrent C. diff: Using Real-World Data to Guide Treatment Strategies
Air Date: Thursday, November 19, 2024
Sponsored by: FERRING PHARMACEUTICALS
In honor of C. diff Awareness Month, the IDSA Foundation hosted a webinar that provided the latest insights on recurrent Clostridioides difficile infection. The session highlighted real-world outcomes from newly approved gut microbial therapies and offered a comprehensive look at the ongoing challenges posed by C. diff, recognized as one of the top five most urgent public health threats. Specialists discussed the current landscape of C. diff infections and explored innovative approaches to reducing recurrence, focusing on the benefits of GMT. This webinar provided health care professionals with an opportunity to deepen their understanding of the epidemiology, treatment advancements and patient care considerations surrounding rCDI.
From Diagnosis to Treatment: Navigating the NTM Treatment Landscape
Air Date: Thursday, October 30, 2024
Sponsored by: INSMED
Join us as we celebrate Healthy Lung Month with a webinar as part of the Dr. John G. Bartlett Memorial Education Series. Hosted by the IDSA Foundation and Bronchiectasis and NTM 360, a division of the COPD Foundation, this webinar will explore the intricacies of nontuberculous mycobacterial lung disease, unraveling its profound ramifications for patients and explain effective diagnostic and treatment approaches. With a particular focus on the imperative of early diagnosis, this event will shed light on the need to manage NTM in a comprehensive manner. Moreover, attendees will gain valuable insights into the intricate interplay between NTM and bronchiectasis, further illuminating the landscape of lung health.
Preparing for the 2024-2025 Respiratory Virus Season
Air Date: Thursday, August 29, 2024
Sponsored by: MODERNA
Join us as we kick off the Dr. John G. Bartlett Memorial Education Series in 2024 with a webinar that explores the upcoming respiratory season. The webinar aims to address the combined impact of respiratory syncytial virus, influenza and COVID-19 by highlighting the effectiveness of vaccines in preventing severe illness. It will review the latest vaccination guidelines and recommendations for the 2024-2025 season and provide health care providers with strategies to facilitate informed patient discussions on immunization.
From Awareness to Action: Utilizing the Latest Diagnostics to Eliminate Hepatitis C
Air Date: Thursday, December 7, 2023
Sponsored by: ROCHE
As part of the Dr. John G. Bartlett Memorial Education Series, this webinar will provide a comprehensive overview, including the most recent data, statistics and patterns, and will address the latest and most effective testing and treatment modalities for HCV.
Microbial Modulation: Exploring the Gut’s Role in Antimicrobial Resistance
Air Date: Thursday, November 21, 2023
Sponsored by: SERES THERAPEUTICS
In honor of World AMR Awareness Week, join specialists in infectious diseases and antimicrobial resistance as part of the Dr. John G. Bartlett Memorial Education Series. This webinar will examine the role of the gut microbiome in health and disease, how it influences AMR and how gut microbiome modulation might help combat AMR.
Transformation of Treatment for Recurrent C. diff: The Year of the Microbiome
Air Date: Thursday, November 2, 2023
Sponsored by: FERRING
In honor of C. diff Awareness Month, join experts in infectious diseases and the microbiome as they discuss harnessing the power of the microbiome to break the cycle of recurrent Clostridioides difficile infection. Part of the Dr. John G. Bartlett Memorial Education Series and hosted by the IDSA Foundation, the webinar will include a patient advocate who will recount their treatment journey.
Respiratory Vaccines: Separating Fact from Fiction
Air Date: October 19, 2023
Sponsored by: MODERNA
Join Infectious Diseases Society of America Foundation and National Foundation for Infectious Diseases for the latest webinar in the Dr. John G. Bartlett Memorial Education Series as we examine how vaccines can help to reduce the burden of the 2023-24 respiratory virus season.
2023 Flu Season: Why Timely Testing and Treatment Key to Staying Healthy
Air Date: September 26, 2023
Sponsored by: GENENTECH
Join us as we examine the 2023 influenza season and provide updates related to treatment and testing. Our webinar will explore the imperative aspects of flu management and focus on the significance of timely intervention and diagnostic testing, the efficacy of antiviral interventions, the role of community engagement and critical preventive measures against flu.
Mgen: Unmasking the Stealthy STI During Sexual Health Month
Air Date: September 7, 2023
Sponsored by: Hologic
September is Sexual Health Month. We came together to recognize this observance, raise awareness among the general population and educate health care professionals about prevalent sexually transmitted infections. This installment of the series had a specific focus on Mycoplasma genitalium.
Beyond the Common Cold: RSV’s Unforeseen Consequences and Emerging Prevention Options
Air Date: August 29 2023
Sponsored by: PFIZER
This webinar features two specialists of infectious diseases and respiratory syncytial virus, Dr. Ann Falsey and Dr. Edward Walsh, who explore RSV prevention for vulnerable populations. A part of the Dr. John G. Bartlett Memorial Education Series, the discussion includes the concerns RSV poses for infants and older adults, challenges in identifying infections in older adults and new CDC recommendations on prevention.
Cytomegalovirus in Post-Transplant Patients
Air Date: June 15 2023
Sponsored by: Takeda
Join us as part of the John G. Bartlett Memorial Education Series in Honor of CytomegalovirusInfection (CMV) Awareness Month. Post-transplant CMV is a common complication of hematopoietic cell transplantation and solid organ transplantation. It can cause significant morbidity and mortality in transplant recipients, not only in the early post-transplant phase but for years following transplantation. Infection prevention strategies are a critical element of avoiding complications when caring for high-risk patients. This webinar will provide patients and caregivers with an overview of the infection prevention methods that can help keep transplant recipients healthy and safe after transplantation. This content was financially supported by Takeda but was developed independently from Takeda. The content and opinions expressed in this material are solely those of the IDSA Foundation.
The Fungal Foe Among Us: Candidemia and Invasive Candidiasis Awareness
Air Date: May 25, 2023
Sponsored by: Melinta Therapeutics
May is Fungal Infection Awareness Month in the United States. The purpose of this observance is to increase awareness of fungal infections and their global impact on people. Candida albicans and other related species are yeasts that typically exist within the body and on the skin without causing illness but can lead to candidemia and invasive candidiasis in immunocompromised patient populations. In the United States, candidemia is one of the primary causes of bloodstream infections in hospitalized patients, numbering 25,000 cases annually in the Unites States alone (according to recent CDC estimates) and often resulting in prolonged hospital stays, morbidity, mortality and considerable medical expenses. In fact, each case of candidemia can result in an additional hospitalization period of 3 to 13 days and between $6,000 to $29,000 in health care costs.
The Microbiome and C. diff – Can the Gut Defend Against Infection?
Air Date: November 29, 2022
Sponsored by: Ferring Pharmaceuticals
In recognition of Clostridioides difficile Awareness Month, the IDSA Foundation hosted a webinar to discuss how the microbiome can defend against C. diff and other infections. C. diff, a bacterium of the gut that causes diarrhea and inflammation of the colon, affects nearly 500,000 Americans each year. One in six patients will experience recurrence within 2-8 weeks of infection. Risk factors include a weakened immune system (including transplant, HIV and cancer patients); being 65 or older; being on antibiotics; or having recently completed a course of antibiotics.
Gram Negative Resistance – Hiding in Plain Sight
Air Date: November 18, 2022
Sponsored by: AbbVie
The IDSA Foundation hosted the Gram Negative Resistance – Hiding in Plain Sight webinar in honor of is World Antimicrobial Awareness Week — a global campaign that aims to raise awareness of antimicrobial resistance worldwide and encourage best practices among the general public, health care workers and policymakers to slow the development and spread of drug-resistant infections. Antimicrobial resistance is a serious threat to public health, patient safety and national security. IDSA is working on multiple fronts to strengthen the United States’ response to antimicrobial resistance. Research efforts have been made to meet the urgent need for treatment with success in yielding activity against resistant Gram-negative bacteria by deactivating the mechanism of resistance.
The Burden of C. Diff
Air Date: November 8, 2022
Sponsored by: The Alliance: Seres Therapeutics and Aimmune Therapeutics
The IDSA Foundation hosted The Burden of C. Diff webinar in honor of Clostridioides difficile (C. diff) Awareness Month, which is an effort to bring greater attention to a disease that affects nearly 500,000 Americans each year. The focus of this awareness month is to reduce the burdens of C. diff by educating medical students, residents, fellows, and clinicians about the research, prevention, early detection, and lifesaving therapies being done. Additionally, we will hear from a patient advocate to hear about the immeasurable impact and burden of C. diff.
The Continuous Challenges of Non COVID Respiratory Tract Infections
Air Date: September 15, 2022
Sponsored by: Thermo Fisher Scientific
The ISDA Foundation hosted the The Continuous Challenges of Non COVID Respiratory Tract Infections Webinar to address Non-COVID respiratory tract infections as we approach the upcoming cold and flu season. While most upper respiratory infections can resolve on their own, lower respiratory tract infections can pose a challenge, especially for infants, the elderly and the immunocompromised. Currently, lower respiratory tract infections are the third leading cause of death in the world after heart disease and stroke and are the leading cause of death in countries of low economic status. While there is a vast amount of learning and research on respiratory tract infections and the microorganisms that cause them, the discussion of scientific facts is constantly evolving. Given the COVID 19 pandemic, measures to prevent the spread of RTIs have become a widely discussed topic. Within laboratory settings, the testing and diagnostics for RTIs have become an even more important topic.
Post-Transplant Infectious Diseases in honor of National Minority Donor Awareness Month
Air Date: August 23, 2022
Sponsored by: Takeda Pharmaceuticals
In honor of National Minority Donor Awareness Month, on August 23, 2022, the IDSA Foundation hosted a Post-Transplant Infectious Diseases webinar. This webinar was held to promote awareness around the current need for organ donors within multicultural communities, and to provide donation education. As well, this webinar covers prevention, diagnosis, and management of infectious diseases post-transplant, with a focus on Cytomegalovirus (CMV).
Hepatitis C: Elimination in the US and Updated Models of Care
Air Date: July 28, 2022
Sponsored by: AbbVie
On World Hepatitis Day, July 28, 2022, the IDSA Foundation hosted Hepatitis C: Elimination in the US and Updated Models of Care, a webinar discussing the goal to overcome barriers to HCV care and improve diagnosis, treatment and cure rates in different populations.
The Importance of HIV Testing in Different Population Groups
Air Date: June 27, 2022
Sponsored by: Roche Diagnostics
The webinar aims to raise awareness on who, when, and how individuals should get tested to learn about HIV status.
PrEP Implementation in Primary Care: Overcoming the Barriers of HIV Testing
Air Date: June 14, 2022
Sponsored by: Roche Diagnostics
The IDSA Foundation hosted PrEP Implementation in Primary Care: Overcoming the Barriers of HIV Testing, a webinar aiming to help healthcare providers with the various aspects of HIV testing needs, including when and how to screen and monitor different populations so that recent HIV infection is never missed.
Seeing the Unseen: HCV In Marginalized Populations
Air Date: May 24, 2022
Sponsored by: AbbVie
The IDSA Foundation hosted Seeing the Unseen: HCV In Marginalized Populations, a webinar discussing HCV in marginalized patient populations as part of Hepatitis Awareness Month. Hosted by Staci Lockhart PharmD, BCPS, AbbVie Hepatology Senior MSL.
HIV Speaks: History, Healing & Hope
Air Date: December 15, 2021
Sponsored by: Seres Therapeutics
The IDSA Foundation hosted HIV Speaks: History, Healing & Hope, a webinar featuring leaders in infectious diseases whose careers intersected the height of the HIV epidemic in the U.S.
C. diff Talk
Air Date: November 18, 2021
Sponsored by: Seres Therapeutics
The Dr. John G. Bartlett Education Series kicked off with C. diff Talk! Eliot Godofsky, MD, FACP, FIDSA; Mark Wilcox, MD, FRCPath; and Kathy Bischoff, C. diff survivor, discussed the pathogenesis of C. diff and their firsthand experience with this devastating infection with more than 170 people during the event.